Cargando…
Recurrent SRSF2 mutations in MDS affect both splicing and NMD
Oncogenic mutations in the RNA splicing factors SRSF2, SF3B1, and U2AF1 are the most frequent class of mutations in myelodysplastic syndromes and are also common in clonal hematopoiesis, acute myeloid leukemia, chronic lymphocytic leukemia, and a variety of solid tumors. They cause genome-wide splic...
Autores principales: | Rahman, Mohammad Alinoor, Lin, Kuan-Ting, Bradley, Robert K., Abdel-Wahab, Omar, Krainer, Adrian R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7050488/ https://www.ncbi.nlm.nih.gov/pubmed/32001512 http://dx.doi.org/10.1101/gad.332270.119 |
Ejemplares similares
-
Mechanism of Nonsense-Mediated mRNA Decay Stimulation by Splicing Factor SRSF1
por: Aznarez, Isabel, et al.
Publicado: (2018) -
HIV-1 transcription is regulated by splicing factor SRSF1
por: Paz, Sean, et al.
Publicado: (2014) -
Splicing factor SRSF6 promotes hyperplasia of sensitized skin
por: Jensen, Mads A., et al.
Publicado: (2014) -
RUNX1 deficiency cooperates with SRSF2 mutation to induce multilineage hematopoietic defects characteristic of MDS
por: Huang, Yi-Jou, et al.
Publicado: (2022) -
SRSF1 and hnRNP H antagonistically regulate splicing of COLQ exon 16 in a congenital myasthenic syndrome
por: Rahman, Mohammad Alinoor, et al.
Publicado: (2015)